Kyle Gano, Chief Business Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 8,380 shares at $103.01 ($862K) on 2020-02-05, disclosed to the SEC on 2020-02-07.
Seasonal sale ($862k) by Chief Business Development Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.01 | 1,013 | $104K | 12.1% |
| 2 | $103.01 | 1,013 | $104K | 12.1% |
| 3 | $103.03 | 703 | $72K | 8.4% |
| 4 | $103.03 | 703 | $72K | 8.4% |
| 5 | $103.08 | 1,974 | $203K | 23.6% |
| 6 | $103.08 | 1,974 |
| $203K |
| 23.6% |
| 7 | $101.41 | 1,000 | $101K | 11.8% |
| Total | $102.86 avg | 8,380 | $862K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $598K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |